The Association of periOperative Registered Nurses (AORN) has posted online for public comment its "Recommended Practice for Prevention of Transmissible Infections."Â
Protecting patients and healthcare practitioners from potentially infectious agent transmission continues to be a primary focus of perioperative registered nurses. The prevention and control of multidrug-resistant organisms (MDROs) requires that all health care organizations implement, evaluate, and adjust efforts to decrease the risk of transmission. The AORN Recommended Practices for the Prevention of Transmissible Infections is intended to guide perioperative RNs in implementing standard precautions and transmission-based precautions (i.e., contact, droplet, airborne) to prevent infection in the perioperative practice setting.
Additional guidance is provided for bloodborne pathogens; personal protective equipment (PPE); immunization; activities of healthcare workers with infections, exudative lesions, and nonintact skin; and emergency preparedness plans. Finally, the document includes guidance for ongoing education and competency evaluation, documentation requirements, policies and procedures, and quality assurance and performance improvement processes.
The opportunity to provide comments is available to AORN members and nonmembers who must register for comment-tracking purposes. If a nonmember does register to comment s/he can use their registration information to comment on all future recommended practices.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.